CZChengrui Zhong

Chengrui Zhong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chengrui Zhong has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Guolin Li

    Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    2 shared publications
  • Yunle Wan

    Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    2 shared publications
  • Huilin Jin

    Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Jiandong Yu

    Department of Hepatobiliary Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510650, Guangdong Province, China

    1 shared publication
  • Jiayan Wu

    Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Taijun Yi

    Department of General Surgery (Hepatobiliary, Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Risk factors, prognostic factors, and nomograms for liver metastasis in stage Tis-T2 colorectal cancer patients from a population-based study

    by Zejin Lin, Zeyu Lin, Taijun Yi, Yongling Liang, Ziyan Mai, Xingyu Li, Chengrui Zhong, Yunle Wan, Guolin Li

    Liver metastasis(LM) is the primary cause of mortality in patients with colorectal cancer. The incidence of liver metastasis in patients with stage Tis-T2 colorectal cancer is uncommon, and there is limited research available. While nomograms have been increasingly utilized in oncology, there is a lack of studies focusing on the diagnosis and prognostic assessment of liver metastasis in patients with stage Tis-T2 colorectal cancer. The data of patients with stage Tis-T2 colorectal cancer diagnosed between 2010 and 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression analyses were conducted to identify the independent risk factors for liver metastasis in patients with stage Tis-T2 colorectal cancer. Additionally, both univariate and multivariate Cox proportional hazards regression analyses were performed to determine the independent prognostic factors in patients with stage Tis-T2 colorectal cancer who had liver metastasis. Subsequently, two nomograms were developed and the results were assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). A total of 11,116 patients diagnosed with stage Tis-T2 colorectal cancer were studied, among whom 190 (1.71%) developed liver metastasis. The identified independent risk factors for liver metastasis in these patients included age, sex, primary tumor size, serum CEA levels, N stage, and histological type. Furthermore, sex, race, primary tumor size, serum CEA levels, and chemotherapy were found to be independent factors influencing the prognosis of patients with stage Tis-T2 colorectal cancer who developed liver metastasis. The accuracy of predicting the risk and prognosis of liver metastasis in these patients was confirmed through various analyses such as ROC curves, calibration curves, DCA curves, and Kaplan-Meier survival curves on both training and validation sets using two nomograms. The two nomograms are considered effective tools for predicting the risk of liver metastasis in patients with stage Tis-T2 colorectal cancer, as well as predicting the prognosis of patients with liver metastasis. These tools can aid in clinical decision-making.


  • JoVE Video Dataset

    by Zejin Lin, Zeyu Lin, Taijun Yi, Yongling Liang, Chengrui Zhong, Ziyan Mai, Jiayan Wu, Zhiping Chen, Zhu Lin, Huilin Jin, et al.

    Robot-assisted pancreaticobiliary junction resection is a surgical technique employed to treat benign duodenal tumors. The procedure involves several key steps: making a longitudinal incision in the duodenum, excising the tumor at the pancreaticobiliary junction, inserting a biliary stent, connecting the biliary and duodenal mucosa, and suturing the duodenal incision during phase I. The robotic system enhances visibility, facilitates precise operations, minimizes duodenal traction injuries to the duodenum and surgical trauma, ensures accurate suture and fixation of bile duct stents, connects the bile duct and duodenal mucosa and reduces postoperative recovery time. Given the complexity of the operation and the associated risk of postoperative duodenal fistula, a thorough preoperative evaluation and meticulous perioperative preparation are crucial. Prior to the procedure, a comprehensive assessment was conducted, integrating the patient's medical history, family history, serological tests, and imaging studies. Special emphasis was placed on determining the benign or malignant nature of the tumor and evaluating the status of the duodenal artery blood supply network to ascertain the feasibility and efficacy of the surgery. During the operation, efforts were made to minimize duodenal trauma and avoid compromising the duodenal artery blood supply network. Additionally, the use of bile duct stents was considered essential to prevent biliary strictures, facilitate bile discharge, and mitigate biliary complications. Postoperatively, real-time monitoring of amylase and jaundice indicators in drainage fluid informed the timely removal of drainage tubes in accordance with the enhanced recovery after surgery (ERAS) protocol. Subsequent follow-up indicated a successful recovery, characterized by a notable reduction in preoperative abdominal pain, the absence of long-term complications, and no evidence of tumor recurrence. Consequently, robot-assisted pancreaticobiliary junction resection demonstrates a safe and effective surgical approach for the treatment of benign duodenal tumors.